Source link : https://newshealth.biz/health-news/treatment-intensification-slows-metastatic-hormone-sensitive-prostate-cancer/
CHICAGO — Men with metastatic castration-sensitive prostate cancer (mCSPC) and DNA repair alterations had significantly longer progression-free survival (PFS) with a targeted drug plus an androgen receptor pathway inhibitor (ARPI), results from an international randomized trial showed. Radiographic (r)PFS at 3 years improved from 50% with enzalutamide (Xtandi) and placebo to 77% with enzalutamide plus […]
The post Treatment Intensification Slows Metastatic Hormone-Sensitive Prostate Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-31 14:46:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8